Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
Efficacy Claims & footnotes
-
For efficacy claims in promotional pieces, what is the minimum requirement of support required? Can we footnote the supporting data or lead the user to the HCP website where the complete data information can be found?
Or if we include a softer efficacy claim for a product will a CTA to the HCP website suffice?
Thanks
-
Hi @joao-borges
Thank you for your question. In general, Code section 3.1 provides direction on requirements for substantiation. Please also see our resource link for types of marketing benefit claims and tips for levels support for each type.
The efficacy claim itself determines whether supporting information is required to appear prominently in the body copy of the APS (rather than a footnote). Linking to an HCP website with the data is generally not acceptable. For fundamentals on substantiating claims and other topics, we also suggest our new PAAB 1.0 training course.
-
@jennifer-carroll Thank you this was very helpful
